(Eli Lilly, which makes another GLP-1 drug, tirzepatide, was also included in the lawsuit.) The new research, based on health insurance claims from 2006 to 2020 from more than 5,000 patients in the U.S., looked at how many people developed one of four serious gastrointestinal problems biliary disease, gastroparesis, pancreatitis or bowel obstructions after they were prescribed one of the weight loss drugs
This work was supported by the National Natural Science Foundation of China (grant numbers 82202989, 82573498)
For gestalt language processors, the basic unit of language is not a word
However, GLP-1RAs are also associated with substantial adverse events and out-of-pocket costs, which could contribute to their discontinuation
Methods 20 , 11791182 (2023)
Retatrutide deserves serious attention, but it requires serious scrutiny in equal measure